* Avinger Inc AVGR.OQ reported a quarterly adjusted loss
of
$1.82 per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-2.92. The lone analyst forecast for the quarter was for a
loss of $2.03 per share.
* Revenue fell 9.2% to $1.65 million from a year ago;
analysts
expected $1.64 million.
* Avinger Inc's reported EPS for the quarter was a loss of
$1.82.
* The company reported a quarterly loss of $4.06 million.
* Avinger Inc shares had fallen by 14.6% this quarter and
lost 70.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Avinger Inc is
$5.00
This summary was machine generated from LSEG data November 8 at
09:03 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -2.03 -1.82 Beat
Jun. 30 2024 -0.43 -2.82 Missed
Mar. 31 2024 -1.35 -2.49 Missed
-3.93